Fundz

Altimmune Appoints Linda M. Richardson as Chief Commercial Officer

PUBLIC · ALTSep 15, 2025

Position

Chief Commercial Officer

Company

Altimmune

Linda M. Richardson
lrichardson@altimmune.com
MorristownBiotechnologyHealth CareTherapeuticsBiopharmaresearch

Description

Altimmune, Inc has announced the appointment of Linda M Richardson as Chief Commercial Officer, effective September 16, 2025. With over 30 years of experience, she is set to lead the company’s commercial readiness initiatives.

Quick answer

Altimmune Appoints Linda M. Richardson as Chief Commercial Officer (September 15, 2025). Altimmune is based in Morristown, New Jersey, United States.

Who is the new Chief Commercial Officer at Altimmune?
Altimmune named Linda M. Richardson Chief Commercial Officer, announced September 15, 2025.
What did Altimmune announce on September 15, 2025?
Altimmune, Inc has announced the appointment of Linda M Richardson as Chief Commercial Officer, effective September 16, 2025. With over 30 years of experience, she is set to lead the company’s commercial readiness initiatives.
What does Altimmune do?
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases.
Where is Altimmune based?
Altimmune is based in Morristown, New Jersey, United States.
Which similar companies made leadership changes around the same time?
Cantargia AB (August 18, 2025), Genentech (September 17, 2025), Nuvig Therapeutics (September 9, 2025) and Parabilis Medicines (September 3, 2025) also announced leadership changes within 45 days of Altimmune.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Altimmune, and when

A new leader at Altimmune brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Altimmune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Altimmune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Altimmune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Altimmune

Location

Morristown, New Jersey, United States

About

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Karen
Likely contact at this company
••••••••@••••••••

See Karen's verified email →

Siavoche
Likely contact at this company
••••••••@••••••••

See Siavoche's verified email →

Sarah
Likely contact at this company
••••••••@••••••••

See Sarah's verified email →

Greg
Likely contact at this company
••••••••@••••••••

See Greg's verified email →

Richard
Likely contact at this company
••••••••@••••••••

See Richard's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Altimmune's next move

Learn about Strategic plan

Altimmune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.